Nektar Therapeutics (NKTR) Stock Chart & Stock Price History $1.40 +0.03 (+1.82%) (As of 11:33 AM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Nektar Therapeutics Stock Price Performance5 Day Performance+11.38%1 Month Performance+5.38%3 Month Performance+13.22%6 Month Performance-16.46%Year-To-Date Performance+142.48%1 Year Performance+174.00% Receive NKTR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nektar Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. NKTR Stock Chart for Friday, November, 8, 2024 NKTR Chart by TradingView Nektar Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/07/2024$1.39$1.37-1.44%$1.42$1.331.87 million shs$252.19 million11/06/2024$1.40$1.39-0.71%$1.47$1.362.39 million shs$255.87 million11/05/2024$1.33$1.40+5.26%$1.41$1.342.60 million shs$257.71 million11/04/2024$1.23$1.33+8.13%$1.47$1.275.97 million shs$244.83 million11/01/2024$1.19$1.23+3.36%$1.27$1.21842,089 shs$226.42 million10/31/2024$1.25$1.19-4.80%$1.25$1.191.19 million shs$219.05 million Get the Latest News and Ratings for NKTR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nektar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/30/2024$1.27$1.25-1.57%$1.30$1.231.43 million shs$230.03 million10/29/2024$1.36$1.27-6.62%$1.38$1.251.93 million shs$233.71 million10/28/2024$1.32$1.36+3.03%$1.40$1.33967,902 shs$250.27 million10/25/2024$1.35$1.32-2.22%$1.38$1.301.06 million shs$242.91 million10/24/2024$1.41$1.35-4.26%$1.42$1.34967,667 shs$248.43 million10/23/2024$1.44$1.41-2.08%$1.47$1.38883,993 shs$259.47 million10/22/2024$1.39$1.44+3.60%$1.45$1.39705,273 shs$264.99 million10/21/2024$1.41$1.39-1.42%$1.44$1.38643,585 shs$255.79 million10/18/2024$1.45$1.41-2.76%$1.49$1.391.32 million shs$259.47 million10/17/2024$1.38$1.45+5.07%$1.48$1.372.80 million shs$266.83 million10/16/2024$1.29$1.38+6.98%$1.38$1.293.91 million shs$253.95 million10/15/2024$1.32$1.29-2.27%$1.34$1.27754,584 shs$237.39 million10/14/2024$1.36$1.32-2.94%$1.39$1.291.59 million shs$242.91 million10/11/2024$1.29$1.36+5.43%$1.37$1.281.27 million shs$250.27 million10/10/2024$1.30$1.29-0.77%$1.30$1.24737,410 shs$237.39 million10/09/2024$1.30$1.30$1.31$1.28390,447 shs$239.23 million10/08/2024$1.28$1.30+1.56%$1.33$1.28453,404 shs$239.23 million10/07/2024$1.32$1.28-3.03%$1.42$1.261.87 million shs$235.55 million10/04/2024$1.30$1.32+1.54%$1.37$1.29784,911 shs$242.91 million10/03/2024$1.33$1.30-2.26%$1.33$1.261.20 million shs$239.23 million10/02/2024$1.30$1.33+2.31%$1.39$1.262.30 million shs$244.75 million10/01/2024$1.30$1.30$1.35$1.271.65 million shs$239.23 million09/30/2024$1.17$1.30+11.11%$1.34$1.211.28 million shs$239.23 million09/27/2024$1.11$1.17+5.41%$1.27$1.13966,196 shs$215.30 million09/26/2024$1.16$1.11-4.31%$1.17$1.11685,187 shs$204.26 million09/25/2024$1.21$1.16-4.13%$1.20$1.13817,539 shs$213.46 million09/24/2024$1.20$1.21+0.83%$1.22$1.15815,305 shs$222.66 million09/23/2024$1.30$1.20-7.69%$1.31$1.16901,178 shs$220.82 million09/20/2024$1.27$1.30+2.36%$1.32$1.232.40 million shs$239.23 million09/19/2024$1.26$1.27+0.79%$1.33$1.25501,917 shs$233.71 million09/18/2024$1.30$1.26-3.08%$1.32$1.25634,448 shs$231.87 million09/17/2024$1.27$1.30+2.36%$1.34$1.24938,220 shs$239.23 million09/16/2024$1.31$1.27-3.05%$1.30$1.23583,342 shs$233.71 million09/13/2024$1.25$1.31+4.80%$1.34$1.24592,834 shs$241.15 millionTrump’s first crisis (Ad)I’d like to share with you my #1 high-conviction stock to buy before Inauguration Day… and details on the assets that could help you create wealth from these events, even as so many others watch their portfolios destroyed.Everything you need to know is here in my emergency broadcast.09/12/2024$1.25$1.25$1.27$1.21441,883 shs$230.03 million09/11/2024$1.24$1.25+0.81%$1.26$1.20776,389 shs$230.03 million09/10/2024$1.18$1.24+5.08%$1.24$1.15570,930 shs$228.26 million09/09/2024$1.12$1.18+5.36%$1.19$1.12771,848 shs$217.21 million09/06/2024$1.13$1.12-0.88%$1.18$1.081.14 million shs$206.10 million09/05/2024$1.24$1.13-8.87%$1.25$1.12789,381 shs$207.94 million09/04/2024$1.24$1.24$1.29$1.221.15 million shs$228.19 million09/03/2024$1.28$1.24-3.13%$1.31$1.22578,618 shs$228.19 million09/02/2024$1.28$1.28$1.31$1.24560,700 shs$235.55 million08/30/2024$1.27$1.28+0.79%$1.31$1.24560,727 shs$235.55 million08/29/2024$1.26$1.27+0.79%$1.35$1.22755,414 shs$233.71 million08/28/2024$1.25$1.26+0.80%$1.28$1.22874,646 shs$231.87 million08/27/2024$1.36$1.25-8.09%$1.38$1.24487,007 shs$230.03 million08/26/2024$1.35$1.36+0.74%$1.37$1.291.34 million shs$250.27 million08/23/2024$1.21$1.35+12.03%$1.35$1.211.03 million shs$248.43 million08/22/2024$1.27$1.21-5.12%$1.28$1.19400,963 shs$221.74 million08/21/2024$1.28$1.27-0.78%$1.31$1.24560,295 shs$233.71 million08/20/2024$1.33$1.28-3.76%$1.34$1.231.10 million shs$235.55 million08/19/2024$1.25$1.33+6.40%$1.33$1.231.21 million shs$244.75 million08/16/2024$1.19$1.25+5.04%$1.26$1.17654,840 shs$230.03 million08/15/2024$1.14$1.19+4.39%$1.25$1.14903,135 shs$218.98 million08/14/2024$1.15$1.14-0.87%$1.18$1.121.21 million shs$209.78 million08/13/2024$1.11$1.15+3.60%$1.19$1.08822,034 shs$211.62 million08/12/2024$1.11$1.11$1.15$1.09957,114 shs$204.26 million08/09/2024$1.21$1.11-8.26%$1.21$1.111.13 million shs$204.26 million08/08/2024$1.18$1.21+2.54%$1.22$1.141.01 million shs$222.66 million08/07/2024$1.17$1.18+0.85%$1.21$1.161.33 million shs$217.14 million Related Companies ADCT Stock Chart AVIR Stock Chart MCRB Stock Chart PCRX Stock Chart OMER Stock Chart ASMB Stock Chart CPIX Stock Chart AGIO Stock Chart ALKS Stock Chart NVO Stock Chart Receive NKTR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nektar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NKTR) was last updated on 11/8/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredThe secret supplier behind NVIDIA, Tesla and MicrosoftThe Biggest AI firms in the world...Tesla... Microsoft... NVIDIA... Are all relying on a little-known suppl...Behind the Markets | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredTrump’s Victory Just Kicked the Door Open to a…This story is about a division that has been splitting America apart at the seams for the past three and a hal...Banyan Hill Publishing | SponsoredUrgent: This election is riggedI’d like to share with you my #1 high-conviction stock to buy before Inauguration Day… and details on the asse...Porter & Company | SponsoredWhat Trump’s victory means for GOLDGold may have suffered a pullback after news of Trump's 2024 election win spread... But don't be mistaken: ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nektar Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share Nektar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
